vTv Therapeutics Inc. Cl A | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.74 |
Market Cap |
$38.98 M |
Shares Outstanding |
27.26 M |
Public Float |
483.54 K |
Address |
4170 Mendenhall Oaks Parkway High Point North Carolina 27265 United States |
Employees | - |
Website | http://www.vtvtherapeutics.com |
Updated | 07/08/2019 |
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical holding company. The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. |